Balance Sheet

Accounts Payables Accumulated Expenses Assets Cash & Current Investments Cash & Equivalents Common Equity Current Assets Liabilities and Shareholders Equity Payables Prepaid Assets Receivables Receivables - Net Retained Earnings Shareholder's Equity Shares Outstanding Short term Debt Total Current Liabilities Total Debt Total Liabilities

Growth Metrics

Income Statement

Others

Ratios

Bioforce Nanosciences Holdings (BFNH) Cash & Equivalents (2019 - 2025)